Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment by Andrzej Kuźmiński, Tomasz Rosada, Justyna Przybyszewska, Natalia Ukleja-Sokołowska, Zbigniew Bartuzi

“…Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. …”
Get full text

Musician’s dystonia: a perspective on the strongest evidence towards new prevention and mitigation treatments by Joy Grifoni, Joy Grifoni, Valeria Crispiatico, Anna Castagna, Rosa Maria Converti, Marina Ramella, Angelo Quartarone, Teresa L’Abbate, Teresa L’Abbate, Karolina Armonaite, Karolina Armonaite, Luca Paulon, Luca Paulon, Francescaroberta Panuccio, Franca Tecchio

Get full text

Mesenchymal Stem Cells for the Treatment of Spinal Arthrodesis: From Preclinical Research to Clinical Scenario by F. Salamanna, M. Sartori, G. Barbanti Brodano, C. Griffoni, L. Martini, S. Boriani, M. Fini

Get full text

Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs by Nazish Sarfraz, Humera Akram, Afroza Abbas, Sadaf Shaheen, Zoobia Ashiq Awan, Eesha Yaqoob

“…Consulting with a healthcare provider is important to determine the best treatment option based on an individual's specific needs and medical history. …”
Get full text

Image-Based Treatment Planning of the Post-Lumpectomy Breast Utilizing CT and 3TMRI by Geraldine Jacobson, Gideon Zamba, Vicki Betts, M. Muruganandham, Joni Buechler-Price

“…Accurate lumpectomy cavity definition is critical in breast treatment planning. We compared contouring lumpectomy cavity volume and cavity visualization score (CVS) with CT versus 3T MRI. 29 patients were imaged with CT and 3T MRI. …”
Get full text

Performance Evaluation of Produced Water Quality from a Nearshore Oil Treatment Facility by DBM Nwokoma, KK Dagde

“…@JASEM Keywords: Produced water, Oil and Gas, Coastal environment, Pollution, Treatment …”
Get full text

Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China by S. Sweeney, K. Fielding, X. Liu, J.A. Thompson, H. Dong, S. Jiang, Y. Zhao, S. Huan, A. Vassall

“…BACKGROUND: Adherence to TB drugs is crucial for improving treatment outcomes. Digital adherence technologies can improve adherence; however, there is a lack of evidence on cost-effectiveness. …”
Get full text

Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer by Maria Elena Lacruz, Saskia Thies, Andrea Schmidt-Pokrzywniak, Ian Wittenberg, Tobias Engler, Fabian Reinwald, Monika Klinkhammer-Schalke, Sylke Ruth Zeissig, Bianca Franke, Kerstin Weitmann, Atanas Ignatov

“…While metastatic behaviour, treatment and long-term response in HER2-low were comparable to HER2-zero, the hormone receptor status seems to play a critical role in these outcomes.…”
Get full text

Primary Spinal Germ Cell Tumors: A Case Analysis and Review of Treatment Paradigms by Joshua J. Loya, Henry Jung, Caroline Temmins, Nam Cho, Harminder Singh

“…As such, there are no established treatment paradigms. We describe our management for spinal germ cell tumors and a review of the literature. …”
Get full text

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema by Fatima Shafqat Khan, Asfandyar Asghar, Brig Rana Intisar-ul-haq, Tehmina Nazir, Naila Obaid, Munazza Aslam

“…Data were analyzed using SPSS with a significance threshold of p < 0.05. Results: Both treatment groups exhibited improved BCVA and reduced CMT. …”
Get full text

Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment by Christof Meigen, Adrienne Csutak, Patricia Domsa, Éva M Bankó, Judit Körtvélyes, Rita Széchey, Krisztina Lantos, Zoltán Zsolt Nagy

“…Patients reported consistent satisfaction with treatment, with minimal side effects, which diminished over the year.Conclusion In the European population, astigmatism, young age and severe maternal myopia are risk factors for suboptimal outcomes following DIMS therapy. …”
Get full text

Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria by Hidetoshi Takahashi, Atsushi Fukunaga, Koremasa Hayama, Takayoshi Sasajima, Ayako Fujishige, Ryohei Ichishita, Naoko Tomimatsu, Eva Hua, Vineeth Varanasi, Alis Burciu, Michihiro Hide, Thomas Severin

“…Results: From a total of 66 CSU patients (80.3% females; mean ± SD age 46.4 ± 13.2 years; mean ± SD baseline UAS7 28.7 ± 6.5) enrolled, 53 patients (80.3%) reported ≥1 TEAE during the study, with no severe or serious adverse events, no anaphylaxis events and low frequency of TEAEs leading to treatment discontinuations (6.1%). Absolute mean CFB of UAS7 showed a rapid onset of response at Week 4 (−14.2) with further improvement until end of treatment at Week 52 (−22.9). …”
Get full text

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab by Meng Wu, Claudia A.M. Fulgenzi, Antonio D’Alessio, Alessio Cortellini, Ciro Celsa, Giulia F. Manfredi, Bernardo Stefanini, Y. Linda Wu, Yi-Hsiang Huang, Anwaar Saeed, Angelo Pirozzi, Tiziana Pressiani, Lorenza Rimassa, Martin Schoenlein, Kornelius Schulze, Johann von Felden, Yehia Mohamed, Ahmed O. Kaseb, Arndt Vogel, Natascha Roehlen, Marianna Silletta, Naoshi Nishida, Masatoshi Kudo, Caterina Vivaldi, Lorenz Balcar, Bernhard Scheiner, Matthias Pinter, Amit G. Singal, Joshua Glover, Susanna Ulahannan, Fredrich Foerster, Arndt Weinmann, Peter R. Galle, Neehar D. Parikh, Wei-Fan Hsu, Alessandro Parisi, Hong Jae Chon, David J. Pinato, Celina Ang

“…Background &amp; Aims: Atezolizumab/bevacizumab (A/B) is now a standard first-line treatment for advanced hepatocellular carcinoma (HCC), but the optimal second-line regimen is not known. …”
Get full text

EFFECTIVENESS OF HORMONAL TREATMENT IN PATIENTS WITH COMBINED ENDOMETRIAL PATHOLOGY AND BENIGN FORMATIONS OF MAMMARY GLANDS by Yu. S. Shapoval

“…Issues related to the treatment of HPE are still very relevant, which is due to the high frequency of relapses of this disease. …”
Get full text

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis by Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales

“…<br /><strong>Conclusions:</strong> early indicators of response to treatment with interferon beta-1a were identified; that help assess the response to treatment early, which has a positive impact on the evolution of the disease.…”
Get full text

Neuro-endoscopic lavage treatment for pyogenic ventriculitis: A case series and literature review by Dongjie Zhou, Zhi Hu, Ao Shen, Peizhi Zhou

Get full text

Successful Treatment of Tumor-Induced Osteomalacia by Multidisciplinary Therapy with Radiation to Intracranial Fibromyxoid Tumor by Mariangela Massaccesi, Francesco Miccichè, Mario Rigante, Gianluigi Petrone, Elisabetta Lepre, Maria Antonietta Gambacorta, Vincenzo Valentini

“…After five years from treatment, the patient is free from local tumor relapse, TIO progression, and radiation-induced side effects. …”
Get full text

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment by Fatih Ciftci, Ali Can Özarslan, İmran Cagri Kantarci, Aslihan Yelkenci, Ozlem Tavukcuoglu, Mansour Ghorbanpour

Get full text

Clustering and drivers of symptoms observed at week six after antidepressant treatment in depressed outpatients by Michel Danon, Daphnée Poupon, Philippe Courtet, Philip Gorwood

“… Abstract Background Depressive symptoms remaining after antidepressant treatment increase the risk of relapse and recurrence. …”
Get full text

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens? by E. Pontali, M. Raviglione

“…In June 2024, WHO released ‘Key updates to the treatment of drug-resistant tuberculosis: rapid communication’, after the preliminary publication of results from two clinical trials: ‘BEAT-Tuberculosis’ and ‘endTB’. …”
Get full text